Two Sigma Advisers’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
314,900
+202,200
| +179% | +$1.02M | ﹤0.01% | 1227 |
|
|
2025
Q1 | $730K | Buy |
112,700
+37,900
| +51% | +$246K | ﹤0.01% | 1613 |
|
|
2024
Q4 | $549K | Buy |
74,800
+32,000
| +75% | +$235K | ﹤0.01% | 1741 |
|
|
2024
Q3 | $321K | Sell |
42,800
-30,700
| -42% | -$230K | ﹤0.01% | 1884 |
|
|
2024
Q2 | $654K | Buy |
+73,500
| New | +$654K | ﹤0.01% | 1775 |
|
|
2023
Q4 | – | Sell |
-15,900
| Closed | -$149K | – | 2655 |
|
|
2023
Q3 | $149K | Buy |
+15,900
| New | +$149K | ﹤0.01% | 2151 |
|
|
2023
Q2 | – | Sell |
-10,900
| Closed | -$254K | – | 2674 |
|
|
2023
Q1 | $254K | Buy |
+10,900
| New | +$254K | ﹤0.01% | 2199 |
|